Efficacy and Safety of Fibrin Sealant (FS) VH S/D-APR for Hemostasis and Wound Healing in Endoscopic Browlift

Nguyen, Davis B., M.D.

Status: Unknown

Conditions: Compare Ecchymosis and Edema for Fibrin Sealant and no Fibrin Sealant

Treatments: Drug: Fibrin Sealant (Artiss)

Study type: Observational

Funder types: Industry

Identifiers

NCT01320514

Endoscopic Browlift

Details and patient eligibility

About

The primary objective is to evaluate the safety and efficacy of Artiss (Fibrin Sealant) in reducing the incidence of early postoperative bruising and swelling.

Enrollment: 10 estimated patients

Sex: All

Ages: 18 to 75 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Subjects planned for endoscopic browlift, subjects who read, understand and sign the written informed consent, healthy female or male subjects, 18-75 years old, and subjects who are able and willing to comply with the protocal requirements

Exclusion criteria

• Subjects who had previous browlift, subjects indicated for concurrent facial surgeries, subjects considered to be active smokers, subjects with ecchymosis/edema on day 0, significant laboratory abnormalities, subjects with known bleeding or coagulation disorders, subjects treated with anti-coagulants.

Trial design

10 participants in 1 patient group

Fibrin Sealant (Artiss)

Treatment:

Drug: Fibrin Sealant (Artiss)